Chongwei Shi Advances Genetic Research Through DNA Microarray Technology Principles and Applications
A recent study highlights how DNA microarray technology enables high-throughput gene analysis, supporting variation detection, expression ...
Antibody Specificity Testing Market is expected to Reach to US $1.9 Bn by 2035, Driven by Rising Demand for Personalized ...
News-Medical.Net on MSN
AI turns routine pathology slides into powerful maps of the tumor immune landscape
A large study shows that routine H&E pathology slides contain rich spatial proteomic signals that can be decoded by AI to ...
The Melanoma Research Alliance launched a national biorepository at the University of Colorado to collect melanoma samples, focusing on rare subtypes for diagnostic and treatment research.
The biochips market is poised for robust growth driven by technological advancements and increased healthcare needs.
North America remains the largest contributor to the global exosomes market, driven by substantial R&D investments, expanding clinical trials, and strong collaborations between biotechnology companies ...
Detailed price information for Bionano Genomics Inc (BNGO-Q) from The Globe and Mail including charting and trades.
The global Proteomics Market is on a rapid growth trajectory, projected to reach USD 134.82 billion by 2035 from an estimated USD 44.79 billion in 2025, reflecting a robust CAGR of 11.7%. Driven by ...
Pregnancy loss affects nearly one in four pregnancies, with most miscarriages occurring in the first trimester and roughly half linked to genetic or chromosomal abnormalities. When these losses happen ...
Cell free RNA diagnostics market is projected to reach US$ 204.5 Mn by 2035, expanding at a CAGR of 14.5% from 2025 to 2035 ...
This valuable study presents an analysis of the gene regulatory networks that contribute to tumour heterogeneity and tumor plasticity in Ewing sarcoma, with key implications for other fusion-driven ...
Biocoat today announced the formation of Surmodics Services & Technologies, a newly named division that will carry forward the portion of Biocoat's business remaining after merging with Surmodics and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results